Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-16-521392
Filing Date
2016-03-29
Accepted
2016-03-29 16:03:07
Documents
79
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d41327d10k.htm 10-K 853394
2 EX-10.23 d41327dex1023.htm EX-10.23 75580
3 EX-10.24 d41327dex1024.htm EX-10.24 75650
4 EX-10.25 d41327dex1025.htm EX-10.25 75638
5 EX-23.1 d41327dex231.htm EX-23.1 1937
6 EX-31.1 d41327dex311.htm EX-31.1 6336
7 EX-31.2 d41327dex312.htm EX-31.2 6311
8 EX-32.1 d41327dex321.htm EX-32.1 4498
  Complete submission text file 0001193125-16-521392.txt   5025936

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT cbay-20151231.xml EX-101.INS 793205
10 XBRL TAXONOMY EXTENSION SCHEMA cbay-20151231.xsd EX-101.SCH 55527
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbay-20151231_cal.xml EX-101.CAL 75184
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbay-20151231_def.xml EX-101.DEF 188834
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbay-20151231_lab.xml EX-101.LAB 502788
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbay-20151231_pre.xml EX-101.PRE 352196
Mailing Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560
Business Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

EIN.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36500 | Film No.: 161535455
SIC: 2834 Pharmaceutical Preparations